Description

According to a report by StrategyHelix, the global home health monitoring market is set to increase by US$ 27.3 billion during 2022-2028, growing at a CAGR of 17.9% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for home health monitoring. The global home health monitoring market is segmented on the basis of technology, and region. On the basis of technology, the global home health monitoring market has been segmented into blood glucose monitoring (BGM), continuous blood pressure monitoring, continuous glucose monitoring (CGM), continuous pulse-oximetry, spot pulse-oximetry, others. The CGM segment held the largest revenue share in 2021. Geographically, the global home health monitoring market is segmented into Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. Among these, Europe was accounted for the highest revenue generator in 2021.

The continuous glucose monitoring market is further segmented into devices, services, and supplements. Globally, the supplements segment made up the largest share of the home health monitoring market. Furthermore, the blood glucose monitoring market has been categorized into devices, and supplement test strips. The supplement test strips segment was the largest contributor to the global home health monitoring market in 2021. The spot pulse-oximetry market is further divided into consulting, data analytics and insights, and fingertip insert clip. The fingertip insert clip segment is estimated to account for the largest share of the global home health monitoring market.

The global home health monitoring market is highly competitive. The leading players in the home health monitoring market include Abbott Laboratories, AliveCor Inc., BioTelemetry Inc., DexCom Inc., Dragerwerk AG & Co. KGaA, iRhythm Technologies Inc., Masimo Corporation, Medicalgorithmics S.A., Medtronic plc, Nonin Medical Inc., Reckitt Benckiser Group plc, Senseonics Inc. Competitive landscape gives a description of the competitive nature of the global home health monitoring market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the home health monitoring market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Technology: blood glucose monitoring (BGM), continuous blood pressure monitoring, continuous glucose monitoring (CGM), continuous pulse-oximetry, spot pulse-oximetry, others
Region: Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America
Years considered: this report covers the period 2018 to 2028
Company mentioned: Abbott Laboratories, AliveCor Inc., BioTelemetry Inc., DexCom Inc., Dragerwerk AG & Co. KGaA, iRhythm Technologies Inc., Masimo Corporation, Medicalgorithmics S.A., Medtronic plc, Nonin Medical Inc., Reckitt Benckiser Group plc, Senseonics Inc.

Key Benefits for Stakeholders

– Get a comprehensive picture of the global home health monitoring market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Home health monitoring market overview
Part 3. Market breakdown by technology
– Blood glucose monitoring (BGM)
– Continuous blood pressure monitoring
– Continuous glucose monitoring (CGM)
– Continuous pulse-oximetry
– Spot pulse-oximetry
– Others
Part 4. Market breakdown by region
– Asia Pacific
– Europe
– North America
– MEA (Middle East and Africa)
– Latin America
Part 5. Key companies
– Abbott Laboratories
– AliveCor, Inc.
– BioTelemetry, Inc.
– DexCom, Inc.
– Dragerwerk AG & Co. KGaA
– iRhythm Technologies, Inc.
– Masimo Corporation
– Medicalgorithmics S.A.
– Medtronic plc
– Nonin Medical, Inc.
– Reckitt Benckiser Group plc
– Senseonics, Inc.
About StrategyHelix
Disclaimer